Table 1.
Baseline characteristics of patients with gastric cancer and synchronous liver metastasis
| Characteristics | GTC (n = 32) | SC (n = 75) | P |
|---|---|---|---|
| Patient-related factors | |||
| Age (years) | 60.5 ± 18.0 | 58.4 ± 17.8 | 0.277 |
| Sex, n (%) | 0.612 | ||
| Male | 31 (96.9) | 69 (92.0) | |
| Female | 1 (3.1) | 6 (8.0) | |
| ECOG performance status, n (%) | 0.270 | ||
| 0–1 | 27 (84.4) | 56 (74.7) | |
| 2 | 5 (15.6) | 19 (25.3) | |
| Primary gastric cancerrelated factors | |||
| Size (cm), n (%) | 0.534 | ||
| <6 | 18 (56.2) | 47 (62.7) | |
| ≥6 | 14 (43.8) | 28 (37.3) | |
| Tumor location, n (%) | 0.269 | ||
| Lower | 16 (50.0) | 30 (40.0) | |
| Middle | 4 (12.5) | 23 (30.7) | |
| Upper | 11 (34.4) | 20 (26.7) | |
| Whole | 1 (3.1) | 2 (2.6) | |
| Histologic classification, n (%) | 0.814 | ||
| Well differentiated | 1 (3.1) | 3 (4.0) | |
| Moderately differentiated | 6 (18.8) | 19 (25.3) | |
| Poorly differentiated | 24 (75.0) | 52 (69.3) | |
| Undifferentiated | 1 (3.1) | 1 (1.3) | |
| Liver metastases-related factors | |||
| Tumor size (cm), n (%) | 0.816 | ||
| <3 | 15 (46.9) | 38 (50.7) | |
| ≥3 | 17 (53.1) | 37 (49.3) | |
| Extent of liver metastases, n (%) | 0.108 | ||
| H1 | 7 (21.9) | 11 (14.7) | |
| H2 | 12 (37.5) | 17 (22.7) | |
| H3 | 13 (40.6) | 47 (62.7) | |
| Child–Pugh grade, n (%) | 0.409 | ||
| A | 27 (84.4) | 58 (77.3) | |
| B | 5 (15.6) | 17 (22.7) |
GTC: Gastrectomy, TACE, Chemotherapy; SC: Systemic chemotherapy; ECOG: Eastern cooperative oncology group.